Literature DB >> 29750

Premedication for upper gastrointestinal endoscopy: a comparative study of flunitrazepam, diazepam and neuroleptanalgesia.

W S Nimmo, J A Forrest, R C Heading, N D Finlayson, L F Prescott.   

Abstract

Flunitrazepam or diazepam with atropine and a combination of phenoperidine, droperidol and cyclizine (neuroleptanalgesia) were compared as premedication in three groups of 25 patients undergoing routine upper gastrointestinal endoscopy. Drug doses were titrated carefully against response and all three regimes were found to be similar in terms of safety, patient co-operation, relaxation and speed of recovery. Neuroleptanalgesia however produced a statistically significant rise in endtidal pCO2 and systolic blood pressure. The benzodiazepines, and in particular flunitrazepam, produced a significantly greater amnesia for the procedure, patients given these drugs being more willing to undergo repeat endoscopy.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 29750     DOI: 10.1055/s-0028-1098290

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  4 in total

Review 1.  Sedation for fibreoptic bronchoscopy.

Authors:  M P Shelley; P Wilson; J Norman
Journal:  Thorax       Date:  1989-10       Impact factor: 9.139

2.  Postal survey of bronchoscopic practice by physicians in the United Kingdom.

Authors:  F G Simpson; A G Arnold; A Purvis; P W Belfield; M F Muers; N J Cooke
Journal:  Thorax       Date:  1986-04       Impact factor: 9.139

3.  Midazolam for upper gastrointestinal endoscopy.

Authors:  P Kawar; K G Porter; E K Hunter; J McLaughlin; J W Dundee; T O Brophy
Journal:  Ann R Coll Surg Engl       Date:  1984-07       Impact factor: 1.891

4.  Effect of flunitrazepam as an oral hypnotic on 24-hour blood pressure in healthy volunteers.

Authors:  Daniele Bosone; Roberto Fogari; Annalisa Zoppi; Angela D'Angelo; Natascia Ghiotto; Giulia Perini; Matteo Cotta Ramusino; Alfredo Costa
Journal:  Eur J Clin Pharmacol       Date:  2018-04-30       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.